Shrinidhi Nathany on Simulating Cells and Why It is a Game Changer
Shrinidhi Nathany, Consultant Molecular Hematology and Oncology at Fortis Memorial, posted on LinkedIn:
“Thought provoking read
What if we could simulate the cell?
For years, the idea of a virtual cell sounded unrealistic. Cells are complex, dynamic, and shaped by countless molecular interactions. Today, that view is changing.
With advances in single cell biology, spatial omics, perturbation data, and AI, scientists are beginning to build models that can predict how cells respond to genes, drugs, and environmental signals. These are not perfect replicas, but practical, predictive systems.
Virtual cells could transform drug discovery and precision medicine by allowing millions of experiments to be run computationally, guiding lab work, improving patient selection, and helping match the right therapy to the right patient.
The challenges are real, especially data scale and quality. But the direction is clear.
Making the cell predictable would redefine how we study disease and design treatments. The virtual cell is no longer science fiction. It is becoming a new tool for biology.”
Title: Inside the Virtual Cell: New Depths for Precision Medicine
Authors: Clara Rodriguez Fernandez
Read full article here.
Stay informed with Hemostasis Today.
-
Sep 23, 2026, 12:45Lina Camacho-Arteaga: ENTIS Study Uncovers Safety Data on Early Pregnancy Exposure to Direct Oral Anticoagulants
-
Sep 23, 2026, 12:34Hiteshi K.C. Chauhan: Why Mechanical Valve Thrombosis Is a Systems Failure, Not Just an Anticoagulation Error
-
Sep 23, 2026, 12:33World Thrombosis Day 2026 Puts Women’s Health in Focus – JTH
-
Sep 23, 2026, 12:30Zain Khalpey: How a Sudden Blockage Causes Myocardial Infarction
-
Sep 23, 2026, 12:16Apurva Popat: When Heparin Triggers Thrombosis
-
Sep 23, 2026, 12:14Zahra Ghasemi: The Power of Voluntary Blood Donation
-
Sep 23, 2026, 12:04Leo Nicolai: Activated Platelets Get Trapped in the Spleen During Thrombosis
-
Sep 23, 2026, 12:01Francisco Chacón-Lozsán: Rethinking PE Risk in 2026
-
Sep 23, 2026, 11:58Ifeanyichukwu Ifechidere: Factor V Leiden Requires Context Beyond the Genetic Result